Final Results of TACTICS: A Randomized, Prospective Trial Comparing Transarterial Chemoembolization Plus Sorafenib to Transarterial Chemoembolization Alone in Patients with Unresectable Hepatocellular CarcinomaMasatoshi Kudo, Kazuomi Ueshima, Masafumi Ikeda et al.|Liver Cancer|2022Cited by 134
The copper chelator trientine has an antiangiogenic effect against hepatocellular carcinoma, possibly through inhibition of interleukin‐8 productionMichihisa Moriguchi, Keizo Kagawa, Tomoki Nakajima et al.|International Journal of Cancer|2002Cited by 96
Oncogenic miR-96-5p inhibits apoptosis by targeting the caspase-9 gene in hepatocellular carcinomaN. Iwai, Yoshito Itoh, Kohichiroh Yasui et al.|International Journal of Oncology|2018Cited by 82
Genome-wide DNA methylation analysis in hepatocellular carcinomaNobuhisa Yamada, Yoshito Itoh, Kohichiroh Yasui et al.|Oncology Reports|2016Cited by 79
S-1 versus placebo in patients with sorafenib-refractory advanced hepatocellular carcinoma (S-CUBE): a randomised, double-blind, multicentre, phase 3 trialMasatoshi Kudo, Takuji Okusaka, Michihisa Moriguchi et al.|The Lancet. Gastroenterology & hepatology|2017Cited by 60